Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

Yevgeniy Balagula, Claus Garbe, Patricia L. Myskowski, Axel Hauschild, Bernardo L. Rapoport, Christine B. Boers-Doets, Mario E. Lacouture

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The last decade in oncology has been highlighted by the emergence of novel, highly specific anti-cancer agents, targeting a variety of molecular structures and able to inhibit aberrantly activated oncogenic pathways. Epidermal growth factor receptor inhibitors (EGFRIs) represent one type of such "targeted" agents. Their use made treatment more tolerable and resulted in significant reduction of systemic adverse effects. However, EGFRIs are associated with toxicities affecting the skin and adnexal structures, and mucosal surfaces that affect the majority of treated patients. Significant dermatologic toxicities have changed the role and involvement of dermatologists in their care. It is essential to be familiar with these adverse effects, potential complications, long-term sequelae, and available effective treatment strategies in order to appropriately manage these patients. This review will describe the clinical presentation, histopathology, underlying mechanisms, and management options, emphasizing evidence-based approaches.

Original languageEnglish (US)
Pages (from-to)129-146
Number of pages18
JournalInternational Journal of Dermatology
Volume50
Issue number2
DOIs
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Molecular Structure
Skin
Therapeutics
Neoplasms
Dermatologists

ASJC Scopus subject areas

  • Dermatology

Cite this

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. / Balagula, Yevgeniy; Garbe, Claus; Myskowski, Patricia L.; Hauschild, Axel; Rapoport, Bernardo L.; Boers-Doets, Christine B.; Lacouture, Mario E.

In: International Journal of Dermatology, Vol. 50, No. 2, 02.2011, p. 129-146.

Research output: Contribution to journalArticle

Balagula, Yevgeniy ; Garbe, Claus ; Myskowski, Patricia L. ; Hauschild, Axel ; Rapoport, Bernardo L. ; Boers-Doets, Christine B. ; Lacouture, Mario E. / Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. In: International Journal of Dermatology. 2011 ; Vol. 50, No. 2. pp. 129-146.
@article{e1a6636fcb66421ba7bcc1af85c66294,
title = "Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors",
abstract = "The last decade in oncology has been highlighted by the emergence of novel, highly specific anti-cancer agents, targeting a variety of molecular structures and able to inhibit aberrantly activated oncogenic pathways. Epidermal growth factor receptor inhibitors (EGFRIs) represent one type of such {"}targeted{"} agents. Their use made treatment more tolerable and resulted in significant reduction of systemic adverse effects. However, EGFRIs are associated with toxicities affecting the skin and adnexal structures, and mucosal surfaces that affect the majority of treated patients. Significant dermatologic toxicities have changed the role and involvement of dermatologists in their care. It is essential to be familiar with these adverse effects, potential complications, long-term sequelae, and available effective treatment strategies in order to appropriately manage these patients. This review will describe the clinical presentation, histopathology, underlying mechanisms, and management options, emphasizing evidence-based approaches.",
author = "Yevgeniy Balagula and Claus Garbe and Myskowski, {Patricia L.} and Axel Hauschild and Rapoport, {Bernardo L.} and Boers-Doets, {Christine B.} and Lacouture, {Mario E.}",
year = "2011",
month = "2",
doi = "10.1111/j.1365-4632.2010.04791.x",
language = "English (US)",
volume = "50",
pages = "129--146",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

AU - Balagula, Yevgeniy

AU - Garbe, Claus

AU - Myskowski, Patricia L.

AU - Hauschild, Axel

AU - Rapoport, Bernardo L.

AU - Boers-Doets, Christine B.

AU - Lacouture, Mario E.

PY - 2011/2

Y1 - 2011/2

N2 - The last decade in oncology has been highlighted by the emergence of novel, highly specific anti-cancer agents, targeting a variety of molecular structures and able to inhibit aberrantly activated oncogenic pathways. Epidermal growth factor receptor inhibitors (EGFRIs) represent one type of such "targeted" agents. Their use made treatment more tolerable and resulted in significant reduction of systemic adverse effects. However, EGFRIs are associated with toxicities affecting the skin and adnexal structures, and mucosal surfaces that affect the majority of treated patients. Significant dermatologic toxicities have changed the role and involvement of dermatologists in their care. It is essential to be familiar with these adverse effects, potential complications, long-term sequelae, and available effective treatment strategies in order to appropriately manage these patients. This review will describe the clinical presentation, histopathology, underlying mechanisms, and management options, emphasizing evidence-based approaches.

AB - The last decade in oncology has been highlighted by the emergence of novel, highly specific anti-cancer agents, targeting a variety of molecular structures and able to inhibit aberrantly activated oncogenic pathways. Epidermal growth factor receptor inhibitors (EGFRIs) represent one type of such "targeted" agents. Their use made treatment more tolerable and resulted in significant reduction of systemic adverse effects. However, EGFRIs are associated with toxicities affecting the skin and adnexal structures, and mucosal surfaces that affect the majority of treated patients. Significant dermatologic toxicities have changed the role and involvement of dermatologists in their care. It is essential to be familiar with these adverse effects, potential complications, long-term sequelae, and available effective treatment strategies in order to appropriately manage these patients. This review will describe the clinical presentation, histopathology, underlying mechanisms, and management options, emphasizing evidence-based approaches.

UR - http://www.scopus.com/inward/record.url?scp=78751622165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751622165&partnerID=8YFLogxK

U2 - 10.1111/j.1365-4632.2010.04791.x

DO - 10.1111/j.1365-4632.2010.04791.x

M3 - Article

C2 - 21244375

AN - SCOPUS:78751622165

VL - 50

SP - 129

EP - 146

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 2

ER -